RxDoctor Payments Data

Aseem Malhotra, MD

Urology · Manassas, VANPI 1942654041

Payments from drug & device makers

What this record shows

This record is dominated by grants: $35,000 of the $56,070 with a category attached, or 62.4%. Boston Scientific accounts for 62.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $35,000 and has fallen 53.2% since, to $16,379 in 2025. Among urology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,070in general payments, 2019–2025

Across 65 payments — averaging $862.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$35K
  • Laborie Medical Technologies Corp.$13K
  • Ferring Pharmaceuticals Inc.$3K
  • Urogen Pharma, Inc.$2K
  • Intuitive Surgical$737
  • Medtronic$518
  • plus $2K from 16 others

What the payments were for

  • Consulting fees$14,95827%
  • Speaking & faculty fees$2,0404%
  • Grants$35,00062%
  • Travel & lodging$8361%
  • Food & beverage$3,2356%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,070 in reported general payments places this provider in the 90th percentile of 300 urology providers in Virginia.

See all urology providers in Virginia

Medicare billing

Part B allowed, 2024
$383,103
Medicare patients
763
Services billed
6,986

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide19$268,500
OrgovyxRelugolix58$166,594
MyrbetriqMirabegron66$43,390
GemtesaVibegron15$19,137
Abiraterone Acetate18$6,605
Methenamine Hippurate76$5,925
Trospium Chloride98$5,860
Tamsulosin Hcl416$4,754
Estradiol52$3,796
Trospium Chloride ErTrospium Chloride14$2,012
Solifenacin Succinate35$1,324
Finasteride75$1,234
Silodosin24$1,102
Desmopressin Acetate18$694
Tolterodine Tartrate ErTolterodine Tartrate19$480

Paid to pharmacies, not to this prescriber.

Other urology in Manassas

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →